HTLV-1 seropositive patients with lung cancer treated with PD-1 inhibitors

Yasuto Yoneshima; Koji Kato; Haruna Minami; Munehiko Ikeda; Hiroyuki Watanabe; Goichi Yoshimoto; Toshihiro Miyamoto; Koichi Akashi; Yoichi Nakanishi; Isamu Okamoto

doi:10.1111/cas.14536

HTLV-1 seropositive patients with lung cancer treated with PD-1 inhibitors

Yasuto Yoneshima, Koji Kato, Haruna Minami, Munehiko Ikeda, Hiroyuki Watanabe, Goichi Yoshimoto, Toshihiro Miyamoto, Koichi Akashi, Yoichi Nakanishi, Isamu Okamoto

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	3395-3396
Number of pages	2
Journal	Cancer Science
Volume	111
Issue number	9
DOIs	https://doi.org/10.1111/cas.14536
Publication status	Published - Sept 1 2020

All Science Journal Classification (ASJC) codes

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/cas.14536

Cite this

@article{73a98d4e747c44a69327c7b064262888,

title = "HTLV-1 seropositive patients with lung cancer treated with PD-1 inhibitors",

author = "Yasuto Yoneshima and Koji Kato and Haruna Minami and Munehiko Ikeda and Hiroyuki Watanabe and Goichi Yoshimoto and Toshihiro Miyamoto and Koichi Akashi and Yoichi Nakanishi and Isamu Okamoto",

year = "2020",

month = sep,

day = "1",

doi = "10.1111/cas.14536",

language = "English",

volume = "111",

pages = "3395--3396",

journal = "Cancer Science",

issn = "1347-9032",

publisher = "Wiley-Blackwell",

number = "9",

}

TY - JOUR

T1 - HTLV-1 seropositive patients with lung cancer treated with PD-1 inhibitors

AU - Yoneshima, Yasuto

AU - Kato, Koji

AU - Minami, Haruna

AU - Ikeda, Munehiko

AU - Watanabe, Hiroyuki

AU - Yoshimoto, Goichi

AU - Miyamoto, Toshihiro

AU - Akashi, Koichi

AU - Nakanishi, Yoichi

AU - Okamoto, Isamu

PY - 2020/9/1

Y1 - 2020/9/1

UR - http://www.scopus.com/inward/record.url?scp=85088147097&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85088147097&partnerID=8YFLogxK

U2 - 10.1111/cas.14536

DO - 10.1111/cas.14536

M3 - Letter

C2 - 32557883

AN - SCOPUS:85088147097

SN - 1347-9032

VL - 111

SP - 3395

EP - 3396

JO - Cancer Science

JF - Cancer Science

IS - 9

ER -

HTLV-1 seropositive patients with lung cancer treated with PD-1 inhibitors

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this